COVID-19: Tokyo Medical University predicts aggravation of blood particles: “exosomes”
COVID-19: Chugai’s Actemra: Roche, 3P start in the world
Ivermectin Could Turn COVID-19 Around. We Need To Find Out If It Works.
COVID-19: Eisai to jointly develop therapeutic drug: Utilization of Eritoran and E6011